Cancer Therapeutics CRC

CTx, a collaborative research and commercial partnership, is in the business of finding cures for adult and children’s cancers. A major focus is developing adjuvant-by-design drugs to target micrometastases and redesigning clinical trials to test these drugs’ ability to reduce recurrence. Four novel CTx drugs have already been licensed for development.

View Site